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Objective: Advanced age is considered a relative contraindication for surgical revascularization in patients with peripheral
arterial occlusive disease. Our aim was to analyze the usefulness of endovascular and surgical revascularization in patients
older than 80 years with chronic critical leg ischemia (CLI). Our hypothesis was that the clinical benefit of lower extremity
revascularization is limited in octogenarians.
Methods: This was a prospective cohort study with a 1-year follow-up. Subjects included a consecutive series (January 1999
to June 2004) of patients presenting with CLI. Revascularization cohorts were either open surgical or endovascular with
conservatively treated patients as a reference group. Prospective follow-up occurred after 30 days and 2, 6, and 12
months. The primary end point was sustained clinical success, defined as a categorical upward shift in clinical symptoms
according to Rutherford, without major amputation and without the need for repeated target extremity revascularization
(TER). Secondary clinical success was defined accordingly, including repeated TER. Mortality, major amputation, and
TER were separately calculated end points. All results were stratified for age categories of nonoctogenarians (<80 years)
and octogenarians (>80 years). Cumulative outcome was determined by the Kaplan-Meier method, and differences were
assessed by log-rank tests. Multivariable analysis was performed by using Cox proportional regression.
Results: A total of 376 patients (158 women; mean age, 75.8  10.7 years) with 416 critically ischemic limbs were
analyzed. Overall, 150 patients (39.9%) were older than 80 years, and 85 limbs were treated surgically (26 octogenarians;
30.6%), 207 limbs (96 octogenarians; 46.4%) were treated by endovascular means, and 124 limbs (45 octogenarians;
36.3%) were treated conservatively, including delayed revascularization procedures. Both sustained and secondary clinical
success rates, as well as limb salvage rates, were higher in the revascularization cohorts as compared with conservatively
treated patients, regardless of age category (P < .001, P < .001, and P  .006, respectively, by Cox proportional hazard
model). Mortality was significantly higher in octogenarians (P  .006 by Cox proportional hazard model), particularly
within 30 days after surgical revascularization (hazard ratio, 5.35; 95% confidence interval, 1.15-24.9). Patient age
category did not affect the rate of major amputations or TER.
Conclusions: Individually tailored revascularization improves the outcome of CLI in octogenarians as well as in
nonoctogenarians; even so, endovascular revascularization should be preferred in octogenarians because of the higher
mortality associated with surgery. ( J Vasc Surg 2007;46:1198-207.)Patients with critical limb ischemia (CLI) represent a
subgroup with particularly severe peripheral arterial occlu-
sive disease (PAOD); CLI is associated with very high
morbidity and mortality rates, as well as severely diminished
quality of life.1-3 With aging of the population and im-
proved medical care, vascular physicians face an ever-
increasing number of elderly patients presenting with pro-
gressed forms of PAOD.4 The management of these
patients can be difficult because many have multilevel arte-
rial disease while bearing serious medical comorbidities that
may affect their recovery from operation, quality of life, or
survival.5
CLI patients undergoing successful revascularization
survive longer and have an increased quality of life com-
From the Division of Clinical and Interventional Angiologya and Depart-
ment of Cardiovascular Surgery,b Swiss Cardiovascular Centre, University
Hospital, Bern, and the Baptist Cardiac and Vascular Institute.c
P.B. and F.D. contributed equally.
Competition of interest: none.
Presented at the AHA Scientific Sessions, Orlando, Fla, 2007.
Reprint requests: Iris Baumgartner, MD, Department of Angiology, Swiss
Cardiovascular Center, University Hospital Bern, Freiburgstrasse, 3010
Bern, Switzerland (e-mail: iris.baumgartner@insel.ch).
0741-5214/$32.00
Copyright © 2007 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2007.07.047
1198pared with patients who receive conservative treatment or
undergo primary amputation.6-8 Considering the enor-
mous socioeconomic burden CLI and its treatment are
imposing on health care, however, the identification of
futile efforts becomes increasingly relevant. The benefit of
lower extremity revascularization procedures might be lim-
ited in very elderly patients because of an increased risk of
cardiovascular events.9 Nonetheless, very few studies have
investigated specific issues associated with the usefulness of
revascularization for chronic CLI in elderly patients.5,10,11
Our aim was to assess the usefulness of endovascular
and surgical revascularization in patients with CLI stratified
for age categories above or below 80 years in a prospective
cohort study. Conservatively treated patients, including
those with delayed revascularization, were used as a refer-
ence group. The working hypothesis was that the clinical
benefit of lower extremity revascularization is limited in
octogenarians because of increased associated morbidity
and mortality.
PATIENTS AND METHODS
All patients treated for chronic CLI between January
1999 and June 2004 were prospectively followed up over
12 months at our institution. Approval of the local ethical
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 6 Brosi et al 1199committee had been obtained before the start of the study.
The study was performed according to the Declaration of
Helsinki,12 and all patients had to give informed consent
before inclusion into the study. The definition of CLI
followed current consensus13,14: ie, (1) the presence of
ischemic rest pain for more than 2 weeks or ischemic tissue
loss associated with (2) an absolute ankle pressure less than
50 mm Hg or great toe pressure less than 30 mm Hg.
Patients with acute limb ischemia were excluded.
Recorded patient details comprised demographic base-
line characteristics, clinical presentation, imaging studies,
treatment modality, and prospective follow-up data at 30
days and 2, 6, and 12 months. In view of the advanced age
and comorbidities of CLI patients, a range of 3 weeks
around each scheduled study visit was tolerated. Patients
were followed up more frequently according to individual
clinical requirements, if needed.
Assessment of peripheral circulation was performed at
baseline and every follow-up visit and consisted of a com-
pletely noninvasive vascular workup, including measure-
ments of the systolic blood pressures of both the anterior
and posterior tibial arteries and calculation of the ankle-
brachial index (ABI). Great toe pressure measurements b y
photoplethysmography were added in cases in which
arteries were considered incompressible15 (ABI  1.15)
or oscillometric readings showed poor pulsatility despite
absolute ankle pressures of greater than 50 mm Hg.
Additionally, transcutaneous partial oxygen tissue pres-
sures of the forefoot were recorded in the supine and
sitting positions. Imaging studies—ie, duplex scan, an-
giography, or computed tomography angiography—were
performed in all patients at baseline and during follow-up in
cases in which recurrent stenosis or occlusion or additional
arterial lesions were suspected clinically or hemodynami-
cally. Experienced vascular technicians performed all vascu-
lar laboratory measurements. Grading of the severity of
ischemia followed the classification system proposed by
Rutherford et al.16
Identification of cardiovascular risk factors and the
technique of ABI measurement were based on previously
published definitions.17 Amputations were considered ma-
jor and thus registered if performed above the ankle. Con-
versely, limb salvage was defined as absence of major am-
putation during the observation period: ie, the preservation
of a functional lower limb allowing for standing and walk-
ing without a prosthesis.16
All patients were evaluated on a case-by-case basis by a
dedicated multidisciplinary vascular board including inter-
ventional angiologists, radiologists, and vascular surgeons.
This panel was established according to international
recommendations13 and convened since 1998 for daily
conferences. Departmental guidelines regarding optimal
revascularization were continuously adapted to recommen-
dations,13,14 and a strategy “to treat patients with CLI by
endovascular means whenever technically possible rather
than to operate” was adopted from the beginning of the
recruitment period. Treatment decisions were based on
clinical presentation, urgency of therapy, the general con-dition of the patient (including the presence of limiting
comorbidities and the anatomic distribution and morpho-
logic nature of vascular lesions), the availability of autolo-
gous vein material, and access for endovascular therapy. For
analysis, revascularization procedures were classified into
either open surgical or endovascular revascularization.
In cases of prohibitive lesion patterns or patient refusal
or if the overall clinical situation suggested a cautious
attitude, CLI was treated conservatively. Patients with de-
layed revascularization procedures were classified as to be
conservatively treated according to an intention-to-treat
analysis. The best medical therapy, including analgesic,
antibiotic, and antiplatelet/antithrombotic therapy, as well
as lipid-lowering, antihypertensive, and diabetes medica-
tion and, infrequently, prostaglandins, was applied equally
to all treatment cohorts.18,19 During follow-up, the same
multidisciplinary panel was involved in treatment decisions
regarding the need for repeated target extremity revascu-
larizations (TER) and major amputations, using the same
criteria. Decisions on repeated TER were invariably based
on vascular imaging in addition to clinical findings. Our
institutional protocol stipulates deliberate use of repeated
endovascular interventions in patients for bypass salvage,
whereas we do not routinely perform endovascular redo
procedures in the absence of worsening symptoms after
primary endovascular treatment. Data sets with missing
baseline information or without any follow-up data were
excluded from analysis.
Study end points. End point definitions were adapted
to currently existing guidelines.20 The primary study end
point was sustained clinical success, defined as clinical im-
provement without the need for repeated TER and without
major amputation.16 In this context, clinical improvement
was defined according to Rutherford et al16: ie, a categor-
ical upward shift of at least one clinical category for all
categories except for baseline category 5 (upward shift of at
least two clinical categories) in combination with a hemo-
dynamic improvement of either ABI or toe-brachial index
(both of at least 0.1) or oscillometric reading. Secondary
clinical success followed the same criteria but was not cen-
sored for repeated TER. Secondary study end points were
cumulative rates of patient mortality, major amputation,
and repeated TER (endovascular or open surgical).
Periprocedural mortality was defined as either 30-day or
in-hospital mortality.
Statistical methods. Data were analyzed according to
the intention-to-treat principle. Two categories were dis-
tinguished in each treatment cohort: patients aged at least
80 years (octogenarians) and patients younger than 80
years (nonoctogenarians).
Continuous data are given as mean  SD, if normally
distributed, and as median with absolute range if asym-
metrically distributed. Categorical data are given as counts
and percentages. Preprocedural patient characteristics, co-
morbidities, risk factors, lesion characteristics, and details
regarding endovascular and open surgical procedures were
correlated with the predefined study groups by bivariable
analysis.
. TER
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groups were assessed by two-tailed Fisher exact tests for
discrete variables and by two-tailed unpaired t tests or
Mann-Whitney U tests for continuous variables.
Clinical success rates and secondary end points were
assessed by cumulative outcome estimates according to
Kaplan-Meier as recommended.16,20 Patients were uncen-
sored in the event of major amputation or repeated TER
and whenever clinical improvement was either never
reached or lost. Differences in outcome were assessed by
applying the log-rank test. Multivariable regression analysis
by Cox proportional hazard model was used to correct for
other risk factors. Differences are expressed as hazard ratios
with 95% confidence intervals. P values of .05 were con-
sidered to represent statistical significance. All analyses were
performed with SPSS 13.0 for Windows (version 13.0.1;
SPSS Inc, Chicago, Ill).
RESULTS
A total of 383 consecutive patients with 426 chronic
critically ischemic limbs were treated and recorded during
the study period. Ten (2%) data sets were excluded from
analysis because of missing baseline information (patient
refusal to undergo vascular imaging [n  2] or any form of
treatment [n  2] or withdrawal of informed consent [n 
1]) or lack of any follow-up data (because of relocation to
other cantons [n  3] or countries [n  2]). Of the
remaining 416 limbs, 124 were treated conservatively; 85
Fig 1. Treatment decision flowchartunderwent surgical and 207 underwent endovascular revas-cularization (Fig 1). Primary major amputation was re-
quired in 16 patients (4%). Demographic information,
lesion characteristics, and revascularization procedures are
outlined in Tables I and II.
Initial decisions to not attempt revascularization (108
limbs, control group, conservative treatment; Fig 1) were as
follows: revascularization was deemed not immediately
necessary (n  41), there was missing consent to any
intervention (n  14), local disease was considered to be
inaccessible for both surgery and percutaneous translumi-
nal angioplasty (PTA; n  39) or only for accessible PTA
and unfit for surgery (n  6), or revascularization was
postponed because of predominant systemic disease (n 
8). In that cohort, delayed arterial revascularization was
performed in 29 limbs (cumulatively 37.5%) after a median
of 49 days (mean, 82  80 days; range, 1-327 days)
because of a change of mind about initial refusal (n  8), a
change of clinical situation in cases initially deemed not
urgent (n  15), and improved general condition either
rendering open surgery possible (n  4) or rendering
endovascular therapy reasonable (n  2).
Cumulative outcome results according to age strata are
outlined in Tables III and IV. Except for patients undergo-
ing conservative treatment, ABI improved significantly be-
tween baseline and the 1-month follow-up and remained
unchanged thereafter (Table V).
Primary efficacy end points. No differences in sus-
tained clinical success rates were found in comparing octo-
, Target extremity revascularization.genarians with nonoctogenarians in bivariable or multiva-
utcom
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model; Table IV). However, sustained clinical success rates
were significantly higher in octogenarians (P  .001 by
Table I. Demographic characteristics in octogenarians (
critical limb ischemia
Characteristic Octogenarians (n
Age, y, mean  SD (range) 85.4  3.8 (80.0
Females, n (%) 85 (56.7
Risk factors and comorbidity, n (%)
Smoking 45 (30.0
Dyslipidemia 78 (52.0
Diabetes 65 (43.3
Hypertension 118 (78.7
Impaired renal function† 42 (28.0
*Calculated by the Fisher exact test for discrete variables.
†Impaired renal function  serum creatinine  115mol/L.
Table II. Lesion characteristics and revascularization proc
Characteristic Octogenarians (16
Rest pain, n (%) 31 (18
Ischemic lesions, n (%) 136 (81
ABI at baseline (mean  SD) 0.45  0.2
Level of arterial obstruction, n (%)†
Iliac 18/122‡ (14
Femoropopliteal 94/122‡ (77
Infrapopliteal 78/122‡ (63
Treatment cohort, n (%)
Conservative 45 (27
Revascularization 122 (73
Endovascular revascularization 96 (57
Open surgical 26 (15
ABI, Ankle-brachial index.
*Calculated by Fisher test for discrete and Mann-Whitney test for continuo
†Data of 292 limbs undergoing surgical or endovascular revascularization
octogenarians.
‡Number of endovascular or surgically treated arteries.
Table III. Cumulative 30-day and 1-year mortality rates,
categories (80 years [octogenarians] versus 80 years [n
Patient outcome
(n  376)
Octogenarians,
n  150 (39.9%)
Nonoctogena
n  226 (60
30-d mortality rate 16 (11%) 10 (4.7
Conservative 6/41 (17.9%) 4/71 (6.6
Revascularization 10/109 (9.3%) 6/155 (3.9
Endovascular 5/84 (6%) 5/101 (5%
Surgery 5/25 (20%) 1/54 (1.9
1-y mortality rate 52 (38.7%) 48 (24
Conservative 20/41 (56.3%) 18/71 (30
Revascularization 32/109 (33.0%) 30/155 (21
Endovascular 23/84 (31.7%) 22/101 (23
Surgery 9/25 (37.4%) 8/54 (16
HR, Hazard ratio for octogenarians; CI, confidence interval; NS, not signifi
*Calculated by log-rank analysis.
†Adjusted for sex, diabetes, hypertension, renal disease, smoking, treatment
class; P values were calculated by the Cox proportional hazard model.
‡No Cox proportional hazard model was used because there were too few olog-rank test and P .013 by the Cox proportional hazardsmodel) and in nonoctogenarians (P  . 002 by log-rank
test and P .006 by the Cox proportional hazards model)
after revascularization as compared with conservative treat-
ears) and nonoctogenarians (80 years) with chronic
0) Nonoctogenarians (n  226) P value*
) 69.3  8.9 (40.3-79.9)
73 (32.3) .0001
151 (66.8) .0001
135 (59.7) .14
108 (47.8) .40
165 (73.0) .27
59 (26.1) .72
es (data given per limbs analyzed)
bs) Nonoctogenarians (249 limbs) P value*
42 (16.9) .69
207 (83.1) .69
0.47  0.21 .21
35/170‡ (20.6) .22
136/170‡ (80.0) .56
103/170‡ (60.6) .63
79 (31.7) .33
170 (68.3) .33
111 (44.6) .012
59 (23.7) .047
iables.
were revascularized in nonoctogenarians, and 122 were revascularized in
ding risk factor–adjusted hazard ratios comparing age
togenarians])
P value*
Adjusted
P value† HR 95% CI
.021 —‡ —‡ —‡
NS —‡ —‡ —‡
NS —‡ —‡ —‡
NS —‡ —‡ —‡
.005 —‡ —‡ —‡
.030 .006 2.09 1.24-3.53
.004 NS 2.25 0.79-6.42
NS .026 2.05 1.09-3.84
NS NS 1.74 0.84-3.60
.044 .033 5.35 1.15-24.9
(conservative, endovascular, or surgical revascularization), and Rutherford
e events per predictor.80 y
 15
-94.9
)
)
)
)
)
)edur
7 lim
.6)
.4)
2
.8)
.0)
.9)
.0)
.1)
.5)
.6)
us var
: 170inclu
onoc
rians,
.1%)
%)
%)
%)
)
%)
.1%)
.6%)
.3%)
.8%)
.5%)
cant.
groupment (Fig 2). No significant differences in primary treat-
utcom
and 12
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and endovascular revascularization for both age strata and
after multivariable control of confounding factors (P  .05
by Cox proportional hazards model).
Accordingly, secondary clinical success rates were sub-
stantially higher in octogenarians (P  .001 by log-rank
test and P  .004 by Cox proportional hazards model) and
Table IV. Cumulative 1-year clinical success, major ampu
risk factor–adjusted hazard ratios comparing age categories
[nonoctogenarians])
Limb outcome
(n  416)
Octogenarians
(167 limbs)
Nonoctog
(249
Primary clinical success 49 (26.6%) 83
Conservative‡ 5/45 (11.1%) 18/79
Revascularization 44/122 (32.6%) 65/170
Endovascular 34/96 (32.7%) 37/111
Surgery 10/26 (31.7%) 28/59
Secondary clinical success 88 (50.6%) 140
Conservative‡ 10/45 (20.3%) 33/79
Revascularization 78/122 (62.1%) 107/170
Endovascular 60/96 (60.9%) 67/111
Surgery 18/26 (66.6%) 40/59
Major amputation 31 (22.3%) 52
Conservative‡ 13/45 (41.9%) 24/79
Revascularization 18/122 (16.5%) 28/170
Endovascular 15/96 (18.2%) 19/111
Surgery 3/26 (11.8%) 9/59
Repeated TER 58 (48.3%) 77
Conservative‡ 10/45 (42.2%) 20/79
Revascularization 48/122 (49.4%) 57/170
Endovascular 39/96 (49.8%) 40/111
Surgery 9/26 (48.8%) 17/59
HR, Hazard ratio for octogenarians; CI, confidence interval; TER, target e
*Calculated by log-rank analysis.
†Adjusted for sex, diabetes, hypertension, renal disease, smoking, treatment
class. The P value was calculated by using the Cox proportional hazard mo
‡A total of 29 (cumulative 37.5%) of 108 of the initially conservatively treated
follow-up.
§No Cox proportional hazard model was used because there were too few o
Table V. Changes in ankle-brachial index during the stud
Variable Baseline 1 mo 2
All patients 0.46  0.21 0.68  0.27 0.68
Conservative 0.47  0.22 0.57  0.29 0.54
Revascularization 0.46  0.21 0.69  0.26 0.73
Octogenarians 0.45  0.22 0.62  0.26 0.69
Conservative 0.45  0.21 0.38  0.15 0.44
Revascularization 0.45  0.22 0.64  0.25 0.75
Surgical 0.43  0.14 0.67  0.23 0.82
Endovascular 0.46  0.24 0.64  0.26 0.73
Nonoctogenarians 0.47  0.21 0.72  0.27 0.67
Conservative 0.49  0.22 0.65  0.30 0.59
Revascularization 0.47  0.21 0.73  0.26 0.71
Surgical 0.40  0.16 0.80  0.25 0.79
Endovascular 0.52  0.22 0.70  0.26 0.64
Data are ankle-brachial indexes (mean  SD).
*By Wilcoxon test (comparison of ankle-brachial index at baseline vs 30 da
†By Friedman test (comparison of ankle-brachial index at 1 month vs 2, 6,in nonoctogenarians (P  .001 by log-rank test and P .006 by Cox proportional hazards model) after revascular-
ization as compared with conservative treatment (Fig 3),
whereas no significant differences were found in comparing
surgical with endovascular revascularization (P  .05 by
log-rank test and Cox proportional hazards model).
Secondary efficacy end points. The calculated 30-
day mortality rate of the revascularization cohorts was 6.1%
n, and target extremity revascularization rates including
0 years [octogenarians] versus 80 years
ians
P value*
Adjusted
P value† HR 95% CI
2%) NS NS 0.93 0.69-1.26
7%) NS NS 0.93 0.51-1.69
6%) NS NS 0.98 0.68-1.42
7%) NS NS 0.94 0.63-1.40
0%) NS NS 1.12 0.49-2.54
0%) NS NS 0.83 0.57-1.23
0%) .03 NS 1.22 0.62-2.42
6%) NS NS 1.06 0.65-1.73
8%) NS NS 1.13 0.66-1.94
0%) NS NS 0.87 0.27-2.81
6%) NS NS 0.70 0.38-1.31
7%) NS —§ —§ —§
6%) NS NS 0.83 0.40-1.73
7%) NS —§ —§ —§
0%) NS —§ —§ —§
4%) NS NS 1.14 0.76-1.71
1%) NS NS 1.22 0.45-3.33
3%) NS NS 1.12 0.71-1.77
6%) NS NS 1.04 0.63-1.71
2%) NS NS 1.42 0.45-4.51
ity revascularization; NS, not significant.
(conservative, endovascular, or surgical revascularization), and Rutherford
nts underwent a delayed target extremity revascularization procedure during
e events per predictor.
iod
6 mo 12 mo P value* P value†
9 0.65  0.29 0.66  0.25 .001 .17
7 0.60  0.30 0.59  0.27 .42 .35
8 0.66  0.28 0.68  0.24 .001 .28
2 0.60  0.27 0.61  0.25 .001 .13
6 0.47  0.22 0.55  0.28 .14 .10
3 0.62  0.27 0.62  0.24 .001 .45
8 0.72  0.27 0.70  0.26 .001 .72
4 0.59  0.27 0.59  0.23 .001 .52
6 0.68  0.29 0.69  0.25 .001 .24
0 0.66  0.31 0.61  0.27 .65 .96
3 0.69  0.29 0.71  0.25 .001 .21
1 0.78  0.23 0.80  0.21 .001 .60
3 0.63  0.31 0.62  0.25 .001 .41
r enrollment).
months).tatio
(8
enar
limbs)
(31.
(21.
(35.
(30.
(45.
(55.
(41.
(61.
(58.
(67.
(23.
(33.
(18.
(19.
(17.
(40.
(36.
(42.
(45.
(26.
xtrem
group
del.
patiey per
mo
 0.2
 0.2
 0.2
 0.3
 0.1
 0.3
 0.2
 0.3
 0.2
 0.3
 0.2
 0.2
 0.2
ys afte(7.6% surgery vs 5.4% endovascular; not significant). How-
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rate was significantly higher after surgery as compared with
endovascular revascularization (20.0% and 6.0%, respec-
tively; P .030 by log-rank test). Furthermore, the 30-day
mortality rate after surgical revascularization was substan-
tially higher in octogenarians as compared with younger
patients (20% vs 1.9%; P  .005 by log-rank test). Of six
patients who died within 30 days of surgery, five were
octogenarians. Three had undergone aortic procedures,
one had undergone an iliacofemoral procedure, and two
had undergone very distal arterial reconstructions; five pro-
cedures were conducted with patients under general anes-
thesia. Causes of death were cardiac (n  2; 1st and 3rd
Fig 2. Kaplan-Meier estimate of sustained clinical success, de-
fined as clinical improvement according to Rutherford,16 without
the need for repeated target extremity revascularization and with-
out major amputation. (A) Octogenarians; (B) nonoctogenarians.postoperative day [POD]), respiratory failure after pro-longed intubation (n  1; 11th POD), multiorgan failure
(n  2; 5th and 13th PODs, respectively), and pulmonary
embolism (n 1; 5th POD). By contrast, early mortality in
the endovascular cohort (n  10; 5 octogenarians) was
caused by renal failure (n  2; 6th and 7th PODs, respec-
tively), cardiac failure (n  2; 1st and 2nd PODs, respec-
tively), stroke (n  1; 2nd PODs), and pulmonary embo-
lism after return to the nursing home (n 1, 9th POD). In
four cases, causes of death remained unknown.
During follow-up, 100 patients died (52 octogenarians
and 48 younger patients; Table VI). The 1-year overall
mortality rate was significantly higher in octogenarians as
Fig 3. Kaplan-Meier estimate of secondary clinical success, de-
fined as clinical improvement according to Rutherford,16 and
without major amputation but with inclusion of repeated target
extremity revascularization during follow-up. (A) Octogenarians;
(B) nonoctogenarians.compared with nonoctogenarians (P  .030 by log-rank
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Advanced age was particularly associated with higher 1-year
mortality in patients undergoing surgical revascularization
(P  .044 by log-rank test and P  .033 by Cox propor-
tional hazards model).
No statistically significant differences were found in
comparing amputation rates between octogenarians and
nonoctogenarians (P  .05 by log-rank test and by Cox
proportional hazards model). However, limb salvage rates
were significantly higher in both octogenarians (P  .001
by log-rank test and P .041 by Cox proportional hazards
model) and nonoctogenarians (P  .009 by log-rank test
and P  .034 by Cox proportional hazards model) under-
going any form of revascularization as compared with con-
servatively treated patients (Fig 4). No statistically signifi-
cant differences were found in limb salvage rates in
comparing surgical and endovascular revascularization co-
horts within both age strata and after multivariable control
of confounding factors (P  .05 by Cox proportional
hazards model).
No statistically significant differences were found in
rates of freedom from repeated TER in comparing octoge-
narians with nonoctogenarians (P  .05 by log-rank test
and by Cox proportional hazards model) and comparing
surgical and endovascular revascularization within both age
strata and after multivariable control of confounding fac-
tors (P  .05 by log-rank test and by Cox proportional
hazards model).
DISCUSSION
The key finding of this prospective observational co-
hort study was the comparable effect of arterial revascular-
ization on a combination of limb salvage and improvement
in limb function and clinical symptoms in octogenarians
and younger patients. In this respect, no statistically signif-
icant differences were found between endovascular-first
and surgical-first revascularization strategies. Periproce-
dural and 30-day mortality, however, was markedly lower
in the octogenarian endovascular cohort as compared with
the surgical cohort.
Untreated chronic CLI is essentially associated with a
dismal prognosis,3 admittedly depending on the strictness
of the adopted definition of CLI. Indeed, according to a
Table VI. Causes of death of 376 patients with critical
limb ischemia
Variable n (%)
Cardiogenic (heart failure; myocardial infarction) 35 (9.1)
Renal failure 9 (2.3)
Multiorgan failure 5 (1.3)
Pulmonary embolism 3 (0.8)
Respiratory failure (including pneumonia) 8 (2.2)
Stroke 4 (1.0)
Carcinoma 7 (1.8)
Sepsis 9 (2.3)
Unknown 20 (5.2)very strict CLI definition, as used in this investigation,current recommendations call for attempts of arterial re-
construction in any patient if the 1-year probability of
survival and limb salvage can be estimated as higher than
25%.13,21 However, these recommendations do not in-
clude stratification for advanced age, even though, eg, an
increased perioperative risk for serious cardiovascular
events might preponderate in older age categories in such a
way that arterial reconstructions might become prohibi-
tive.22
A major problem in this context is that generally ac-
cepted outcome measures for treatment of CLI have been
lacking until recently. Indeed, a vast heterogeneity of end
points is used in the current literature on CLI which ranges
from limb salvage or mortality rates in most surgical series
to variably assessed patency rates in most endovascular
Fig 4. Cumulative limb salvage in (A) octogenarians and (B)
nonoctogenarians.series. Most importantly, these outcome definitions fail to
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From the patient’s point of view, it is certainly not sufficient
just to postpone amputation until after death.23 Clinical suc-
cess rather depends on survival without major amputation—
ie, preservation of a functional lower limb—but only if this
is combined with symptomatic improvement, preferably
without repetition of an intervention. Hence, in a recent
guideline document, a set of end points was proposed that
permit reliable assessment of clinical efficacy after arterial
revascularization.20 These reporting standards have already
successfully been implemented,17 reflect a real-life outlook
of the individual patient, and are essential to achieve long-
term credibility of arterial revascularization. For this series,
however, the combined efficacy end point was slightly
modified because an unequal effect of mortality probability
in different age categories obviously would have skewed the
results.
It is interesting to note that octogenarians reached
sustained and secondary clinical success rates after revascu-
larization similar to those of nonoctogenarians within 1
year of follow-up. Although these rates may seem rather
low (35% sustained and 62% secondary) when compared
with other reports on “primary clinical success” (range,
64%-79%),5,10,11 the adopted outcome measures are not
directly comparable because of the vast heterogeneity and
incompleteness of study end point definitions, as alluded to
previously. It is known that reconstructive vascular surgery
of the lower limb is associated with substantial periopera-
tive risk. Indeed, perioperative mortality rates for lower
extremity arterial reconstructions range from 2% to
6%.11,24-26 Accordingly, these operations have been clas-
sified as high risk in the current American College of
Cardiology/American Heart Association guidelines on
perioperative cardiovascular risk evaluation.27 Endovas-
cular revascularizations potentially offer critical advantages
such as minimal access trauma, less cardiovascular stress,
low infection rates, and shorter hospital stays.21,28-32
Hence, nowadays PTA is being considered the first-line
therapeutic approach for CLI because its results are similar
to those of reconstructive surgery, even in the infrapopliteal
segment.30,32 It could be assumed that these advantages
would be the more striking the older and multimorbid the
addressed population is. However, infrainguinal PTA was
associated with perioperative mortality rates of up to 6% in
patients aged 76 years and older without a difference com-
pared with surgery.5,33 This series documents a 10-fold
increase in perioperative mortality in octogenarians under-
going reconstructive surgery when compared with younger
patients (1.9% and 20%, respectively; P  .005). Although
the survival advantage of PTA over surgery in octogenari-
ans was lost after 1 year, it can nonetheless be considered
clinically relevant, because surgical treatment did not dis-
play any balancing advantages in this age group that might
justify abandoning an endovascular-first strategy.
In this series, survival after 1 year of follow-up was
significantly improved by arterial revascularization regard-
less of the revascularization modality, thus supporting the
findings of other authors.34 Because this advantage wasconfined to octogenarians, local treatment must still be
considered a palliative treatment approach in the younger
CLI patient population. Thus, younger patients might not
die of local complications but rather of the systemic impli-
cations of PAOD, whereas older, frail patients may tempo-
rarily benefit from local revascularization as a result of
abolished immobility or control of local infection. Other
series did not stratify long-term mortality for age.
Treatment efficacy was significantly improved when
repeated TER was included in the analysis of this series. In
fact, repeated TER improved functional outcomes inde-
pendently in both age categories regardless of the initial
revascularization strategy; this confirms prior observa-
tions.5,10,11 This gain in outcome, however, was achieved
at the cost of multiple interventions. Thus, the effect of
additional health care costs should certainly be assessed in
future studies.
Finally, the overall limb salvage rate at 1 year was well
more than 80% after revascularization, without statistically
significant differences between octogenarians and younger
patients. Compared with other series,35 this is a favorable
result, even though in other series less strict definitions of
CLI were frequently applied.5,35 In this series, revascular-
ization was associated with significantly improved limb
salvage rates as compared with conservative treatment in
both octogenarians and in younger patients. It must be
borne in mind, however, that according to common prac-
tice, patients who underwent primary major amputation
were analyzed within the conservative cohort. Although
their fraction in our collective was extraordinarily low (4%
vs 16%-19% in other series3,13,36), the potential for bias is
still present. After multivariable regression, the strategy of
revascularization (ie, endovascular vs surgical) did not in-
fluence limb salvage rates in either age category, whereas
corresponding limb salvage rates are very comparable to
earlier reports.10,11
STUDY LIMITATIONS
Two shortcomings of the present study have to be
addressed. First, within this prospective study, assignment
of treatment was based on clinical judgment rather than on
randomization. Hence, although the study was controlled,
all disadvantages of a nonrandomized observational study
design may be present. Randomization of a seemingly
homogeneous patient population to treatment techniques
that are basically applicable to different lesion patterns,
however, creates an important ethical dilemma.17 Either
only patients with lesion patterns suitable for both tech-
niques are included, thereby probably creating rather than
preventing a critical selection bias, or assignment of unsuit-
able treatment options to individual patients must be ac-
cepted. Thus, in such a context, even results from random-
ized controlled trials are not transferable to the general
population without restriction.37 The declared aim of this
series was to investigate the outcome of an unselected
spectrum of patients with chronic CLI with the question of
whether advanced patient age influences outcome with
different treatment strategies. With only 10 (2%) excluded
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year in all treatment cohorts, the goal to reflect the real-life
spectrum was satisfactorily achieved. Control was strived
for by predefined selection criteria for treatment assign-
ment within a dedicated multidisciplinary consensus plus
the use of multivariable regression analysis. With these
restrictions in mind, information from this prospective
investigation can be extrapolated to the general popula-
tion as a substitute for randomized controlled investiga-
tions that do not seem applicable in this clinical context
for the above-mentioned reasons. Second, the duration
of follow-up was limited to 1 year in the prospective
study outline of this series. However, given the dismal
outlook for patients with CLI, 1-year follow-up has been
regarded as sufficient intermediate-term or even long-
term follow-up in consensus articles.13,14,38
In conclusion, individually tailored arterial revascular-
ization significantly improves the outcome of chronic CLI
in octogenarians and in younger patients alike. Although
the modality of revascularization did not predictably modify
the outcome at the 1-year follow-up, an endovascular-first
revascularization strategy should be preferred in octogenari-
ans whenever possible because of the high perioperative mor-
tality associated with surgery.
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